Sandor George Vari

Dr. Sandor George Vari

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1991 in The American Journal of Cardiology
Verified
Journal Article
Closed access
PBPeter Barath
Peter Barath
MFMichael C. Fishbein
Michael C. Fishbein
SVSandor George Vari
Sandor George Vari
JFJames S. Forrester
James S. Forrester

21 July 2022 in Life
Verified
Journal Article
Open access
PDF file
LSLivia Simon Sarkadi
Livia Simon Sarkadi
ZMZHANG MIAOMIAO
ZHANG MIAOMIAO
GMGéza Muránszky
Géza Muránszky
Reka Anna VassReka Anna Vass
Reka Anna Vass
OMOksana Matsyura
Oksana Matsyura
SVSandor George Vari
Sandor George Vari
Gestation and the neonatal period are crucial periods in infant development. Many components of breast milk, including fatty acids, play an important role in strengthening the immune system. The aim of our research was to evaluate the fatty acid profiles of milk from 69 mothers, including subjects having a normal weight, obesity, or gestational diabetes. For the analyses, we used gas chromatography (GC) with flame ionization detection (FID) and GC coupled with mass spectrometry (GC/MS). The main fatty acids found in breast milk were palmitic acid (C16:0; 26–28%), linoleic acid (C18:2; 23–28%), and α-linolenic acid linoleic acid (C18:3; 15–17%), followed by myristic acid (C14:0; 5–8%), lauric acid (C12:0; 4–6%) and stearic acid (C18:0; 4–5%). The average breakdown of fatty acids was 50% saturated, 44% polyunsaturated, and 6% monounsaturated. Breast milk samples were classified using principal component analysis and linear discriminant analysis. Results showed that milk from the two major groups of obese and normal body mass index (BMI) could be distinguished with an accuracy of 89.66%. Breast milk samples of Hungarian and Ukrainian mothers showed significant differences based on the fatty acid composition, which variations are attributable to the mothers’ dietary habits.

1 April 2017 in Croatian Medical Journal
Verified
Journal Article
Open access
JHJudit Hajagos-Tóth
Judit Hajagos-Tóth
EDEszter Ducza
Eszter Ducza
RSReza Samavati
Reza Samavati
SVSandor George Vari
Sandor George Vari
RGRobert Gaspar
Robert Gaspar
Obesity is a global health problem even among pregnant women. Obesity alters quality of labor, such as preterm labor, prolonged labor, and higher oxytocin requirements in pregnant women. The most important factors to play a role in the altered gestational ...

20 December 2018 in Cancer Nanotechnology
Verified
Journal Article
Open access
PDF file
LKLesya Kobylinska
Lesya Kobylinska
IPIgor Patereha
Igor Patereha
Nataliya FiniukNataliya Finiuk
Nataliya Finiuk
NMNatalia Mitina
Natalia Mitina
ARAnna Riabtseva
Anna Riabtseva
SVSandor George Vari
Sandor George Vari
Development of biocompatible multifunctional polymeric drug carriers is crucial in modern pharmaceutics aimed to create “smart” drugs. The high potential of the PEGylated comb-like polymeric nanocarrier (PNC) in delivering both traditional and experimental drugs to tumor cells in vitro and in vivo has been demonstrated previously. In the present study, we investigated the general toxicity of polyethylene glycol (PEG) processed with both covalent and non-covalent attachments of PEG to compose a comb-like polymer that behaves like a simple chain of n monomers decorated with swollen side chains. The PNC possesses properties of a water-soluble surfactant containing methyl-terminated PEG side branches in some monomer units attached covalently to the carbon chain backbone. We have demonstrated that the synthesized PNC possesses weak toxic effects toward human leukemia cells (HL-60 and Jurkat lines), as well as toward hepatocellular (HepG2), colon (HCT116) and breast (MCF-7) tumor cell lines. Additionally, after a long period (20 days) of intraperitoneal administration, the PNC had no significant toxic effects in laboratory white mice (470 mg/kg body mass in 1 ml) and Wistar rats (440 mg/kg body mass in 10 ml). The developed PNC we studied can be qualified as a compound of grade 4 toxicity (low toxicity substance). The reduced toxicity of this PNC in combination with its improved bioavailability and previously detected capability to enhance cytotoxicity toward tumor cells in vitro and potential tumor treatment effects in vivo suggests its potential as a safe drug delivery platform for treating various diseases, especially cancer.

1 June 2014 in Croatian Medical Journal
Verified
Journal Article
Open access
LPLivia Puljak
Livia Puljak
SVSandor George Vari
Sandor George Vari

1 February 1993 in Arthroscopy
Verified
Journal Article
Closed access
WSWeiqiang Shi
Weiqiang Shi
SVSandor George Vari
Sandor George Vari
MVMaurits J. van der Veen
Maurits J. van der Veen
MFMichael C. Fishbein
Michael C. Fishbein
WGWarren S. Grundfest
Warren S. Grundfest